pharma · Chemotherapy-induced nausea and vomiting
Biorex Healthcare Pvt
Helsinn Birex Pharmaceuticals Ltd
Helsinn Birex Pharmaceuticals is a pharma organization headquartered in Dublin, IE. Primary therapeutic focus areas include Chemotherapy-induced nausea and vomiting. NovaPharmaNews links 1 clinical program(s), 0 drug pro
Gurugram, IN HQ
2009 Founded
32 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Gurugram, IN
- Founded
- 2009
- Employees
- 32
- Programs
- 1
- Drugs
- 14
- Patents
- 0
NEPA-22-01
Phase 3 · small molecule · Chemotherapy-induced nausea and vomiting
NEPA-22-01 for Chemotherapy-induced nausea and vomiting is a Phase 3 program (small_molecule) at Helsinn Birex Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Internal code NEPA-22-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Helsinn Birex Pharmaceuticals Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Chemotherapy-induced nausea and vomiting
- Status
- active
- Trials
- 1